Table of Contents
From the Editor
- Psychedelics in the medical toolbox?
Given the historical association of psychedelics as “recreational” mind-altering compounds within countercultures of the 1960s and 1970s, their current introduction into several aspects of medical practice is a surprise to many.
The Clinical Picture
- Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
Physical examination in a man who presented with foot pain revealed absent bilateral posterior tibial and dorsalis pedis pulses and dusky erythema of both feet.
1-Minute Consult
- Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?
Clinical judgment should guide this decision, taking into account patient symptoms and the presence of factors that may delay gastric emptying and increase risk for aspiration.
Guidelines to Practice
- 2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What’s new?
The author highlights key changes and recommendations of the new guideline, how they differ from previous and other society guidelines, and ongoing challenges and unresolved issues in perioperative care.
Review
Most elderly patients with subclinical hypothyroidism do not need to be treatedAge-adjusted thyrotropin reference ranges, consideration of individual circumstances, and a wait-and-see approach for mild subclinical hypothyroidism might be more suitable than a universal treatment strategy.
Editorial
- Subclinical hypothyroidism: What’s in a name?
Clinicians should remain thoughtful about the variability in aging biology and not be blinded by a name.
Review
- Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Nociplastic pain is characterized by amplification of pain transmission and pain perception and does not involve visible tissue injury or damage, which makes it difficult to understand and manage.
- Psychedelics, spirituality, and existential distress in patients at the end of life
The authors explore the role of psychedelics in addressing patients’ spiritual and existential suffering at the end of life from a medical, ethical, and legal perspective.
